✦ LIBER ✦

Preface: Malignant syndrome in Parkinson's disease

✍ Scribed by H. Narabayashi; Y. Mizuno

Book ID: 117751865
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 45 KB
Volume: 9
Category: Article
ISSN: 1353-8020
DOI: 10.1016/s1353-8020(02)00139-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Malignant syndrome in Parkinson's diseas

Malignant syndrome in Parkinson's disease

✍ Gurutz Linazasoro 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Neuroleptic malignant syndrome in advanc

Neuroleptic malignant syndrome in advanced Parkinson's disease

✍ P.H. Gordon; S.J. Frucht 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 720 KB

## Abstract Neuroleptic malignant syndrome is a serious complication of levodopa withdrawal in patients with Parkinson's disease. We report a patient with advanced parkinsonism who developed neuroleptic malignant syndrome in the setting of inadequate levodopa intake. His symptoms improved with levo

Constipation triggered the malignant syn

Constipation triggered the malignant syndrome in Parkinson’s disease

✍ Emina Ogawa; Ryuji Sakakibara; Masahiko Kishi; Fuyuki Tateno 📂 Article 📅 2011 🏛 Springer Milan 🌐 English ⚖ 314 KB

Acute hyponatremia and neuroleptic malig

Acute hyponatremia and neuroleptic malignant syndrome in Parkinson's disease

✍ Gianpietro Sechi; Salvatorica Manca; Giovanni A. Deiana; Davide G. Corda; Agnese 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 554 KB

Malignant syndrome in Parkinson's diseas

Malignant syndrome in Parkinson's disease: concept and review of the literature

✍ Yoshikuni Mizuno; Hideki Takubo; Eiiji Mizuta; Sadako Kuno 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Parkinson's disease/Parkinson syndromes—

Parkinson's disease/Parkinson syndromes—transplantation

📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 282 KB

P a m p l o n a . SPAIN. Recent experimental data suggest that different s t ~i a t a l efferent pathways mediate the actions of D -l and D -2 receptor subtypes in r a t s . In order to know whether this organization is a l s o evident in primates. we studied the ability of SCH 23390